Last reviewed · How we verify

NCT06287697

Energy Expenditure and Body Composition of Infants and Young Children (6-24 Months Old) in Asia

Status unknown Last updated 1 March 2024
What this trial tests

trial testing No intervention in Energy Expenditure in 391 participants. Status unknown.

Timeline
21 January 2020
Primary endpoint
30 November 2024
30 November 2024

Quick facts

Lead sponsorMahidol University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment391
Start date21 January 2020
Primary completion30 November 2024
Estimated completion30 November 2024
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Mahidol University

Who can join

Adults 6 Months to 24 Months, any sex, with Energy Expenditure or Body Composition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project is a collaboration between International Atomic Energy Agency (IAEA), FAO Regional Office for Asia and The Pacific, and Mahidol University, Thailand to carry out the study on doubly-labeled water for assessment of total energy expenditure and body composition among infants and young children aged 6-23 months old. Thailand conducted a longitudinal study with participation from 4 other countries, namely, Pakistan, Philippines, Sri Lanka and Vietnam, in undertaking the same assessments in a cross-sectional design.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Energy Expenditure

Currently open trials in the same condition.

Other Mahidol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06287697.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing